Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, Giffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH.
Liao LM, et al. Among authors: sadeghi s.
Gastroenterology. 2012 Mar;142(3):442-452.e5; quiz e22-3. doi: 10.1053/j.gastro.2011.11.019. Epub 2011 Nov 19.
Gastroenterology. 2012.
PMID: 22108196
Free PMC article.